XML 21 R32.htm IDEA: XBRL DOCUMENT v3.2.0.727
Share-Based Payments (Details 2) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 4 Months Ended 6 Months Ended
Mar. 29, 2015
Mar. 28, 2015
Jun. 30, 2015
Mar. 31, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2015
Jun. 30, 2014
Share-Based Payments                
Allocated share-based compensation     $ 6,616,000   $ 3,665,000   $ 2,231,000 $ 7,116,000
Additional disclosures                
Proceeds from issuance of common stock under stock plans             $ 21,210 $ 1,911
Awards vesting on the one-year anniversary                
Share-Based Payments                
Award vesting period             1 year  
Additional disclosures                
Vesting percentage             25.00%  
Awards vesting on the quarterly basis                
Share-Based Payments                
Award vesting period             3 years  
Additional disclosures                
Vesting percentage             6.25%  
Stock options                
Weighted average assumptions used in fair value calculations                
Expected volatility (as a percent)     54.00%   63.00%   60.00% 66.00%
Expected life (years)     5 years 4 months 24 days   5 years 2 months 12 days   6 years 1 month 6 days 6 years 1 month 6 days
Risk-free interest rate (as a percent)     2.10%   2.20%   1.80% 2.20%
Additional disclosures                
Remaining unrecognized compensation cost related to nonvested awards     $ 19,600     $ 19,600 $ 19,600  
Weighted average remaining requisite service period             2 years 7 months 6 days  
Exercised (in shares)             (1,537,353)  
Proceeds from issuance of common stock under stock plans             $ 20,700  
Employee Stock Purchase Plan                
Share-Based Payments                
Allocated share-based compensation     $ 92,000   $ 105,000   $ 188,000 $ 209,000
Weighted average assumptions used in fair value calculations                
Expected volatility (as a percent)     61.00%   67.00%   61.00% 66.00%
Expected life (years)     6 months   6 months   6 months 6 months
Risk-free interest rate (as a percent)     0.10%   0.10%   0.10% 0.10%
Additional disclosures                
Proceeds from issuance of common stock under stock plans             $ 500  
Shares issued during period             58,398  
Restricted stock awards                
Share-Based Payments                
Allocated share-based compensation     $ 3,877,000   $ 999,000   $ (2,973,000) $ 2,155,000
Additional disclosures                
Remaining unrecognized compensation cost related to nonvested awards     $ 3,300     $ 3,300 $ 3,300  
Weighted average remaining requisite service period             9 months 18 days  
Non-vested shares of restricted stock, Number of Shares                
Nonvested at the beginning of the period (in shares)       1,174,000     1,174,000  
Granted (in shares)             250,000  
Vested (in shares)             (451,000)  
Forfeited (in shares)             (130,000)  
Nonvested at the end of the period (in shares)     843,000     843,000 843,000  
Non-vested shares of restricted stock, Weighted Average Grant Date Fair Value                
Nonvested at the beginning of the period (in dollars per share)       $ 15.15     $ 15.15  
Granted (in dollars per share)             13.02  
Vested (in dollars per share)             15.05  
Forfeited (in dollars per share)             14.57  
Nonvested at the end of the period (in dollars per share)     $ 14.66     $ 14.66 $ 14.66  
Time-based restricted stock awards                
Additional disclosures                
Remaining unrecognized compensation cost related to nonvested awards     $ 7,000     $ 7,000 $ 7,000  
Weighted average remaining requisite service period             2 years 10 months 24 days  
Non-vested shares of restricted stock, Number of Shares                
Nonvested at the end of the period (in shares)     511,000     511,000 511,000  
Time-based restricted stock awards | Officers                
Non-vested shares of restricted stock, Number of Shares                
Granted (in shares)             250,087  
Performance-based restricted stock awards                
Share-Based Payments                
Award vesting period 1 year 1 year            
Allocated share-based compensation $ 9,800 $ 10,500       $ 6,100    
Reversal of cumulative compensation cost       $ 10,500        
Non-vested shares of restricted stock, Number of Shares                
Forfeited (in shares) (117,898)              
Nonvested at the end of the period (in shares)     332,000     332,000 332,000  
Performance-based restricted stock awards | Shares vesting upon FDA approval                
Additional disclosures                
Vesting percentage 50.00% 50.00%            
Performance-based restricted stock awards | Awards vesting on the one-year anniversary of approval from FDA                
Share-Based Payments                
Percentage of reduction on original number of shares 15.00%              
Additional disclosures                
Vesting percentage 50.00% 50.00%            
Performance-based restricted stock awards, M356                
Non-vested shares of restricted stock, Number of Shares                
Granted (in shares)   949,620